Upload
Featured Recent Articles Topics Login Upload

Search Results for 'median cancer'

median cancer published presentations and documents on DocSlides.

Malawi Cancer Consortium Overview
Malawi Cancer Consortium Overview
by min-jolicoeur
Satish Gopal MD MPH. University . of Malawi Colle...
Sipuleucel -T Survival Benefit
Sipuleucel -T Survival Benefit
by calandra-battersby
Sipuleucel. -T was approved based on HR of 0.775 ...
Prostate Cancer Screening in 2013: Reports of its Death Are
Prostate Cancer Screening in 2013: Reports of its Death Are
by min-jolicoeur
Norm D. Smith, M.D.. Associate Professor. Co-Dire...
Managing Breast Cancer in the Genomic Era
Managing Breast Cancer in the Genomic Era
by alida-meadow
Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...
Game Plan Trends in ovarian cancer
Game Plan Trends in ovarian cancer
by alexa-scheidler
Diagnostic work-up. Treatment. The most commonly ...
ASCO 2012 Review Gynecologic Cancer
ASCO 2012 Review Gynecologic Cancer
by welnews
Nelson Teng, M.D., Ph.D.. Director, Gynecologic On...
Significant efforts were made by the Moroccan Ministry of Health as part of the National Cancer Co
Significant efforts were made by the Moroccan Ministry of Health as part of the National Cancer Co
by reagan
Patterns of Care (POC) studies are important to . ...
Disparities in Prostate Cancer Outcomes: Race, Access, and Ancestry
Disparities in Prostate Cancer Outcomes: Race, Access, and Ancestry
by Soulmate
Andrew J Armstrong MD . ScM. FACP. National Allia...
Complex Cancer Late Effects Rehabilitation Service
Complex Cancer Late Effects Rehabilitation Service
by OneAndOnly
(. CCLERS) . Complex Cancer Late Effects Rehabilit...
Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer to identi
Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer to identi
by williams
Foundation Medicine. ctDNA. is good information f...
Myeloma: Symptoms to diagnosis
Myeloma: Symptoms to diagnosis
by samantha
Can we do better?. [Hospital name]. [Date]. What i...
Best of ASCO GU Session Sandy Srinivas.MD
Best of ASCO GU Session Sandy Srinivas.MD
by experimentgoogle
Stanford University. Outline. Abstract #4. :. . I...
Network Audit 2010
Network Audit 2010
by giovanna-bartolotta
Failure to Obtain Histological / Cytological . Co...
Surgery for Metastatic Brain Tumor from Breast Cancer
Surgery for Metastatic Brain Tumor from Breast Cancer
by bella
Tanat Vaniyapong, MD. Neurosurgery Unit, Faculty o...
Metastatic Breast Cancer
Metastatic Breast Cancer
by lindy-dunigan
A sub-focus on specific clinical scenarios. What ...
How to describe a graph
How to describe a graph
by olivia-moreira
Otherwise called. CUSS. 5. In context. You must w...
“Critical & Terminal illness – moving to new Frontiers!”
“Critical & Terminal illness – moving to new Frontiers!”
by luanne-stotts
“How long have I got, doc?”. . -not . a ques...
Andrew H. Ko, MD University of California San Francisco
Andrew H. Ko, MD University of California San Francisco
by test
Gastrointestinal Oncology Program. Treatment of m...
Best practice for chemotherapy for treatment of breast cancer
Best practice for chemotherapy for treatment of breast cancer
by ariel
Andreas Makris. Mount Vernon Cancer Center. Royal ...
Proton Beam Therapy for Liver Cancer is Well Tolerated: Outcomes from the Proton Collaborative Grou
Proton Beam Therapy for Liver Cancer is Well Tolerated: Outcomes from the Proton Collaborative Grou
by DancingDragonfly
Michael Chuong, M.D.. 1,2. , Smith . Apisarnthanar...
Module 3: Chronic Lymphocytic Leukemia
Module 3: Chronic Lymphocytic Leukemia
by CottonTails
Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...
Median PFS: 2.6 months (95% CI, 1.7-3.5)
Median PFS: 2.6 months (95% CI, 1.7-3.5)
by ceila
Median PFS: 1.4 months (95% CI, 1.2-1.6) . Median ...
Endocrine resistance: molecular pathways and rational development of targeted therapies
Endocrine resistance: molecular pathways and rational development of targeted therapies
by spottletoefacebook
Grazia Arpino. Università di Napoli Federico II. ...
Laparoscopic gastric cancer surgery:
Laparoscopic gastric cancer surgery:
by tatiana-dople
Is it time for Upper GI surgeons to follow in the...
Where we are with targeted
Where we are with targeted
by stefany-barnette
therapies . for . cholangiocarcinoma. Professor J...
Efficacy of
Efficacy of
by myesha-ticknor
sorafenib. in patients with . desmoid. -type . f...
Laparoscopic gastric cancer surgery:
Laparoscopic gastric cancer surgery:
by natalia-silvester
Is it time for Upper GI surgeons to follow in the...
Measuring Quality and Value in Oncology
Measuring Quality and Value in Oncology
by conchita-marotz
The Need for Measurement. Payers (Medicare and pr...
XXII WORKSHOP UROLOGIA ONCOLÓGICA
XXII WORKSHOP UROLOGIA ONCOLÓGICA
by lindy-dunigan
Hotel . Solverde. ESPINHO. 10-11 . Março. 2017....
Incidence of Mild Cognitive Impairment
Incidence of Mild Cognitive Impairment
by yoshiko-marsland
(MCI) in. Irradiated . Brain Tumor Survivors. N M...
ASCO 2010:
ASCO 2010:
by phoebe-click
. Highlights from the Annual Clinical Meeting. G...
Approaching
Approaching
by kittie-lecroy
. thirty. . years. from the . fisrt. total ...
Treatment of
Treatment of
by natalia-silvester
Biliary. Cancers. Abby B. Siegel, MD, MS . Colum...
Outcomes of the Shift in Care from Inpatient to Outpatient
Outcomes of the Shift in Care from Inpatient to Outpatient
by giovanna-bartolotta
Stephanie Makepeace. Background. Hysterectomy. Re...
New Ways of Managing Prostate Cancer
New Ways of Managing Prostate Cancer
by olivia-moreira
Jahangeer . M.Malik. Consultant Clinical Oncology...
Case Discussion: Second
Case Discussion: Second
by celsa-spraggs
Opinion. 55 year-old woman with . recurrent . ova...
Case Discussion A 52-year-old man initially presented with
Case Discussion A 52-year-old man initially presented with
by lois-ondreau
nonmuscle. -invasive . bladder cancer. He receive...
Btk inhibition in Mantle cell Lymphoma & CLL
Btk inhibition in Mantle cell Lymphoma & CLL
by test
Simon Rule. Professor of Clinical . Haematology. ...
As it pertains to the last patient in your practice who died of metastatic nonsquamous
As it pertains to the last patient in your practice who died of metastatic nonsquamous
by kittie-lecroy
non-small cell lung cancer (NSCLC) . with no targ...
The Impending D eath of Cancer: A Herculean Task Emerging Therapies 2016
The Impending D eath of Cancer: A Herculean Task Emerging Therapies 2016
by phoebe-click
The Impending D eath of Cancer: A Herculean Task...